Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2863-2869

  Svensson, Johan ^a   Veldhuis, Johannes D ^b   Iranmanesh, Ali ^c   Bengtsson, Bengt Åke ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS FUNCTION; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL;

EID: 0036080364     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8566     Document Type: Article

References (37)

1. Sex steroid induced changes in hepatic enzymes
2. Sexual dimorphism in the control of growth hormone secretion
3. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
4. Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion
5. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
6. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women
7. Regulatory mechanisms of growth hormone secretion are sexually dimorphic
8. Orderliness of hormone release patterns: A complementary measure to conventional pulsatile and circadian analyses
9. Hormone pulsatility discrimination via coarse and short time sampling
10. Evaluation and application of a highly sensitive assay for serum growth hormone (GH) in the study of adult GH deficiency
11. A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency
12. Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation
13. The diagnosis of growth hormone deficiency in children and adults
14. Diagnosis of growth hormone deficiency in adults
15. Diagnosis of growth-hormone deficiency in adults
16. Beyond the somatopause: Growth hormone deficiency in adults over the age of 60 years
17. Insulin-like growth factor-1 in growth hormone-deficient adults: Relationship to population-based normal values, body composition and insulin tolerance test
18. Body composition and quality of life as markers of the efficacy of growth hormone replacement therapy in adults
19. Appraisal of growth hormone (GH) secretion: Evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input
20. Half-life of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin
21. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data
22. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
23. Females secrete growth hormone with more process irregularity than males in both humans and rats
24. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
25. Temporal structure of in vivo growth hormone secretory events in man
26. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy
27. Characterisation of 24 hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy
28. Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery
29. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth-hormone-releasing-hormone (GHRH) pulsatile infusion
30. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous GH-releasing peptide infusion: Pulsatile, entropic, and nyctohemeral mechanisms
31. Longitudinal changes in growth hormone secretory process irregularity assessed transpubertally in healthy boys
32. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1,44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states
33. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans
34. Estrogen and testosterone, but not a non-aromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
35. Actions of estrogen on the pulsatile, nyctohemeral, and entropic modes of growth hormone secretion
36. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth-hormone (GH) secretion
37. Growth hormone-releasing hormone